Review: taking Claritin and Xopenex hfa together


Summary

Drug interactions are reported among people who take Claritin and Xopenex hfa together. This review analyzes the effectiveness and drug interactions between Claritin and Xopenex hfa. It is created by eHealthMe based on reports of 52 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 38,014 users)

Xopenex Hfa

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. (latest outcomes from Xopenex hfa 738 users)

On Sep, 18, 2016

52 people who take Claritin, Xopenex Hfa are studied.


Number of reports submitted per year:

Claritin and Xopenex hfa drug interactions.

Drug effectiveness over time:

Claritin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Xopenex Hfa:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Claritin:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Xopenex Hfa:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Claritin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Xopenex Hfa:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • eye swelling
  • feeling jittery
  • palpitations
  • stomatitis
  • tremor
1 - 6 months:
  • eye swelling
  • feeling jittery
  • palpitations
  • stomatitis
  • cor pulmonale chronic
  • cough
  • fatigue
  • gastrooesophageal reflux disease
  • hypertensive nephropathy
  • malaise
6 - 12 months:
  • cor pulmonale chronic
  • cough
  • fatigue
  • gastrooesophageal reflux disease
  • hypertensive nephropathy
  • malaise
  • musculoskeletal disorder
  • osteoarthritis
  • renal failure chronic
  • restless legs syndrome
1 - 2 years:
  • cor pulmonale chronic
  • restless legs syndrome
  • cough
  • fatigue
  • gastrooesophageal reflux disease
  • hypertensive nephropathy
  • malaise
  • musculoskeletal disorder
  • osteoarthritis
  • renal failure chronic
5 - 10 years:
  • flushing
not specified:
  • malaise
  • cough
  • gastrooesophageal reflux disease
  • hypersensitivity
  • abdominal pain
  • asthma
  • diarrhoea
  • injection site haematoma
  • drug ineffective
  • dyspnoea

Most common drug interactions by gender *:

female:
  • malaise
  • cough
  • abdominal pain
  • asthma
  • diarrhoea
  • hypersensitivity
  • injection site haematoma
  • drug ineffective
  • emphysema
  • gastrooesophageal reflux disease
male:
  • gastrooesophageal reflux disease
  • lethargy
  • sinusitis
  • cough
  • eye swelling
  • feeling jittery
  • palpitations
  • stomatitis
  • abdominal pain upper
  • dyspnoea

Most common drug interactions by age *:

2-9:
  • negativism
  • tremor
10-19:
  • drug ineffective
  • malaise
  • urinary tract infection
  • amnesia
  • asthma
  • blood magnesium decreased
  • blood potassium decreased
  • chest pain
  • device dislocation
  • gastrooesophageal reflux disease
20-29:
  • diabetes mellitus
  • gastrooesophageal reflux disease
  • lactic acidosis
  • malaise
  • mouth ulceration
  • drug ineffective
  • hospitalisation
30-39:
  • anaphylactic reaction
  • asthma
  • back injury
  • bronchitis
  • deep vein thrombosis
  • dysphonia
  • flushing
  • hypersensitivity
  • insomnia
  • laryngospasm
40-49:
  • abdominal pain
  • cough
  • hypersensitivity
  • asthma
  • drug hypersensitivity
  • dyspnoea
50-59:
  • eye swelling
  • feeling jittery
  • palpitations
  • stomatitis
  • cardiac failure
  • cerebrovascular accident
  • emotional distress
  • fall
  • femur fracture
  • fluid retention
60+:
  • gastrooesophageal reflux disease
  • dyspnoea
  • muscle spasms
  • nausea
  • pain
  • fatigue
  • malaise
  • abdominal pain upper
  • asthenia
  • chronic obstructive pulmonary disease

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Claritin and Xopenex hfa?

Can you answer these questions?

More questions for: Claritin, Xopenex hfa

You may be interested in these reviews

More reviews for: Claritin, Xopenex hfa

On eHealthMe, Claritin (loratadine) is often used to treat hypersensitivity. Xopenex hfa (levalbuterol tartrate) is often used to treat asthma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.